Notice to Intent to Sole Source - Surgical Supplies NOI-CC-26-002571
Summary
AI-generated · Feb 05, 2026Surgical supplies for emergency use at the NIH Clinical Center must come from the Surgicel brand line, specifically Surgicel 2 inch by 14 inch absorbable hemostat and Surgicel Fibrillar 4 inch by 4 inch. Because of the urgent need to maintain patient care, the purchase will be sole-sourced to Johnson & Johnson Health Care System, with a projected value under the specified amount and a tight delivery deadline.
Not a request for proposal. The sole-source authority is 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1. Other capable vendors may submit a capability statement for consideration, but the government retains discretion on whether to pursue competition based on responses.
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: JOHNSON & JOHNSON HEALTH CARE SYSTEM. Acquisition Description: The products/supplies are estimated not to exceed $34,807.80 not including shipping cost and is required to be delivered by Feb 19, 2026. Because of the urgency of this medication, only 1 source will be solicited. The supplies must be delivered by 2/19/26. This office became aware of the requirement on 1/19/26. If the required delivery date is not met, it will impact the ability to provide patient care. Description of the supplies or services to be purchased: Products/supplies for emergency needs at the NIH Clinical Center: Surgicel 2in x 14in Absorbable Hemostat (oxidized regenerated cellulose), 1951S Surgicel Fibrillar 4inX4in (10.2CMX10.2CM), 1963 The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference 26-002571) by 12:00 PM eastern standard time on 02/07/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
From Special Notice posted on Feb 04, 2026Notice history
1Details
Award Information
Not yet awarded
Agency
Place of Performance
USA